blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2318439

EP2318439 - METHODS OF ALTERING PERIPHERAL B CELL POPULATIONS AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.06.2012
Database last updated on 13.11.2024
Most recent event   Tooltip29.06.2012Application deemed to be withdrawnpublished on 01.08.2012  [2012/31]
Applicant(s)For all designated states
Rappaport Family Institute for Research in the Medical Sciences
Efron Street P.O.Box 9697
31096 Haifa / IL
[2011/19]
Inventor(s)01 / MELAMED, Doron
8 Yahalom Street
30889 Caesarea / IL
02 / KEREN, Zohar
Klil HaHoresh
22815 Gesher HaZiv / IL
 [2011/19]
Representative(s)Dennemeyer & Associates S.A.
55, rue des Bruyères
1274 Howald / LU
[N/P]
Former [2011/19]Dennemeyer & Associates S.A.
55, rue des Bruyères
1274 Howald / LU
Application number, filing date09787474.719.07.2009
[2011/19]
WO2009IL00706
Priority number, dateUS20080129842P23.07.2008         Original published format: US 129842 P
[2011/19]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010010549
Date:28.01.2010
Language:EN
[2010/04]
Type: A2 Application without search report 
No.:EP2318439
Date:11.05.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 28.01.2010 takes the place of the publication of the European patent application.
[2011/19]
Search report(s)International search report - published on:EP18.03.2010
ClassificationIPC:C07K16/28, A61K39/395
[2011/19]
CPC:
C07K16/2887 (EP,US); A61P31/00 (EP); A61P43/00 (EP);
C07K16/2803 (EP,US); A61K2039/505 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/19]
TitleGerman:VERFAHREN ZUR ÄNDERUNG PERIPHERER B-ZELLEN-POPULATIONEN UND ANWENDUNGEN DAVON[2011/19]
English:METHODS OF ALTERING PERIPHERAL B CELL POPULATIONS AND USES THEREOF[2011/19]
French:PROCÉDÉ DE MODIFICATION DE POPULATIONS DE CELLULES B PÉRIPHÉRIQUES ET UTILISATIONS ASSOCIÉES[2011/19]
Entry into regional phase10.02.2011National basic fee paid 
10.02.2011Designation fee(s) paid 
10.02.2011Examination fee paid 
Examination procedure21.01.2010Request for preliminary examination filed
International Preliminary Examining Authority: EP
10.02.2011Amendment by applicant (claims and/or description)
10.02.2011Examination requested  [2011/19]
01.02.2012Application deemed to be withdrawn, date of legal effect  [2012/31]
08.03.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/31]
Fees paidPenalty fee
Additional fee for renewal fee
31.07.201103   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - THAUNAT OLIVIER ET AL, "B cell survival in intragraft tertiary lymphoid organs after rituximab therapy", TRANSPLANTATION (HAGERSTOWN), (20080615), vol. 85, no. 11, ISSN 0041-1337, pages 1648 - 1653, XP002560544 [X] 1-6,8-13,17 * the whole document *

DOI:   http://dx.doi.org/10.1097/TP.0b013e3181735723
 [X]  - KIM SAMUEL ET AL, "B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models", JOURNAL OF IMMUNOTHERAPY, (200806), vol. 31, no. 5, ISSN 1524-9557, pages 446 - 457, XP009127288 [X] 1-4,9-13,17 * the whole document *

DOI:   http://dx.doi.org/10.1097/CJI.0b013e31816d1d6a
 [X]  - LIU CHENGYANG ET AL, "B lymphocyte - directed immunotherapy promotes long-term islet allograft survival in nonhuman primates", NATURE MEDICINE, (200711), vol. 13, no. 11, ISSN 1078-8956, pages 1295 - 1298, XP002560546 [X] 1-3,10-13 * the whole document *

DOI:   http://dx.doi.org/10.1038/nm1673
 [PX]  - ZARKHIN V ET AL, "A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.", AMERICAN JOURNAL OF TRANSPLANTATION : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF TRANSPLANTATION AND THE AMERICAN SOCIETY OF TRANSPLANT SURGEONS DEC 2008, (200812), vol. 8, no. 12, ISSN 1600-6143, pages 2607 - 2617, XP002560547 [PX] 1-6,9-13,17 * abstract *

DOI:   http://dx.doi.org/10.1111/J.1600-6143.2008.02411.X
 [A]  - JOHNSON SARA A ET AL, "Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity.", ARTHRITIS RESEARCH & THERAPY 2004, (2004), vol. 6, no. 4, ISSN 1478-6362, pages 131 - 139, XP009127158

DOI:   http://dx.doi.org/10.1186/ar1180
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.